GB8722306D0 - Sustained-release formulation - Google Patents

Sustained-release formulation

Info

Publication number: GB8722306D0
Authority: GB; United Kingdom
Prior art keywords: sustained; release formulation; formulation; release
Prior art date: 1987-09-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB878722306A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

APS Research Ltd

Original Assignee

APS Research Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-22

Filing date

1987-09-22

Publication date

1987-10-28

1987-09-22 Application filed by APS Research Ltd filed Critical APS Research Ltd

1987-09-22 Priority to GB878722306A priority Critical patent/GB8722306D0/en

1987-10-28 Publication of GB8722306D0 publication Critical patent/GB8722306D0/en

1988-09-22 Priority to PCT/GB1988/000779 priority patent/WO1989002738A1/en

1988-09-22 Priority to JP50763388A priority patent/JPH03500288A/en

1988-09-22 Priority to EP19880908289 priority patent/EP0386023A1/en

Status Pending legal-status Critical Current

Links

GB878722306A 1987-09-22 1987-09-22 Sustained-release formulation Pending GB8722306D0 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GB878722306A GB8722306D0 (en)	1987-09-22	1987-09-22	Sustained-release formulation
PCT/GB1988/000779 WO1989002738A1 (en)	1987-09-22	1988-09-22	Sustained-release nifedipine formulation
JP50763388A JPH03500288A (en)	1987-09-22	1988-09-22	Extended release nifedipine formulation
EP19880908289 EP0386023A1 (en)	1987-09-22	1988-09-22	Sustained-release nifedipine formulation

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB878722306A GB8722306D0 (en)	1987-09-22	1987-09-22	Sustained-release formulation

Publications (1)

Publication Number	Publication Date
GB8722306D0 true GB8722306D0 (en)	1987-10-28

Family

ID=10624201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB878722306A Pending GB8722306D0 (en)	1987-09-22	1987-09-22	Sustained-release formulation

Country Status (4)

Country	Link
EP (1)	EP0386023A1 (en)
JP (1)	JPH03500288A (en)
GB (1)	GB8722306D0 (en)
WO (1)	WO1989002738A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992001446A1 (en) *	1990-07-20	1992-02-06	Aps Research Limited	Sustained-release formulations
GB9200607D0 (en) *	1992-01-13	1992-03-11	Ethical Pharma Ltd	Pharmaceutical compositions containing nifedipine and process for the preparation thereof
ATE135214T1 (en) *	1992-02-17	1996-03-15	Siegfried Ag Pharma	DOSAGE FORMS WITH EXTENDED RELEASE
IL104192A (en) *	1992-02-17	1998-01-04	Siegfried Ag Pharma	Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
WO1994005262A1 (en) *	1992-09-10	1994-03-17	F.H. Faulding & Co. Limited	Sustained release matrix composition
IT1255968B (en) *	1992-11-27	1995-11-17		PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLIC ACID
US5455046A (en) *	1993-09-09	1995-10-03	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) *	1993-09-09	1998-06-30	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems--amorphous drugs
US5662933A (en) *	1993-09-09	1997-09-02	Edward Mendell Co., Inc.	Controlled release formulation (albuterol)
US6726930B1 (en)	1993-09-09	2004-04-27	Penwest Pharmaceuticals Co.	Sustained release heterodisperse hydrogel systems for insoluble drugs
US6093420A (en)	1996-07-08	2000-07-25	Edward Mendell Co., Inc.	Sustained release matrix for high-dose insoluble drugs
US6056977A (en) *	1997-10-15	2000-05-02	Edward Mendell Co., Inc.	Once-a-day controlled release sulfonylurea formulation
WO2002072064A2 (en) *	2001-03-09	2002-09-19	Dow Global Technologies Inc.	Granular composition comprising an active compound and a cellulose ether and the use thereof
JP4331930B2 (en) *	2001-10-17	2009-09-16	武田薬品工業株式会社	High content granules of acid labile drugs
TW200533391A (en) *	2004-03-25	2005-10-16	Sun Pharmaceutical Ind Ltd	Gastric retention drug delivery system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5846019A (en) *	1981-09-14	1983-03-17	Kanebo Ltd	Nifedipine preparation with prolonged action
PH18946A (en) *	1983-04-21	1985-11-14	Elan Corp Plc	Controlled absorption pharmaceutical composition
IT1178511B (en) *	1984-09-14	1987-09-09	Pharmatec Spa	PROCEDURE FOR THE PREPARATION OF A SOLID FORM FOR ORAL USE BASED ON NIFEDIPINE WITH RELEASE
GB8618811D0 (en) *	1986-08-01	1986-09-10	Approved Prescription Services	Sustained release ibuprofen formulation

1987
- 1987-09-22 GB GB878722306A patent/GB8722306D0/en active Pending
1988
- 1988-09-22 JP JP50763388A patent/JPH03500288A/en active Pending
- 1988-09-22 WO PCT/GB1988/000779 patent/WO1989002738A1/en not_active Application Discontinuation
- 1988-09-22 EP EP19880908289 patent/EP0386023A1/en not_active Ceased

Also Published As

Publication number	Publication date
EP0386023A1 (en)	1990-09-12
JPH03500288A (en)	1991-01-24
WO1989002738A1 (en)	1989-04-06

Publication	Publication Date	Title
GB8724763D0 (en)	1987-11-25	Sustained-release formulations
GB8723896D0 (en)	1987-11-18	Controlled-release formulation
GB8800381D0 (en)	1988-02-10	Formulation process
GB8722306D0 (en)	1987-10-28	Sustained-release formulation
GB8727590D0 (en)	1987-12-31	Formulation
GB8712251D0 (en)	1987-07-01	Formulation
GB8712240D0 (en)	1987-07-01	Pharmaceutical formulation
GB8816028D0 (en)	1988-08-10	Pay-&-display-security
GB8718898D0 (en)	1987-09-16	Gaiter
GB8726262D0 (en)	1987-12-16	Radially-resonant structures
GB8723990D0 (en)	1987-11-18	Structures
GB8720608D0 (en)	1987-10-07	Formulation
GB8729672D0 (en)	1988-02-03	Formulation
GB8720784D0 (en)	1987-10-14	Formulation
GB8714838D0 (en)	1987-07-29	Formulation
GB8706242D0 (en)	1987-04-23	Formulation
GB8713878D0 (en)	1987-07-15	Formulation
GB8713818D0 (en)	1987-07-15	Formulation
GB8730115D0 (en)	1988-02-03	Formulation
HRP940445B1 (en)	1998-10-31	Covered sustained-release forms
GB8728599D0 (en)	1988-01-13	Novel formulation
GB8728533D0 (en)	1988-01-13	Novel formulation
IL84123A0 (en)	1988-03-31	Sustained-release pharmaceutical compositions
GB8716540D0 (en)	1987-08-19	Spread
GB8713858D0 (en)	1987-07-15	Foundue set